| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
- SEC Filing
On April 5, 2024, Immunocore Holdings plc (the "Company") filed a prospectus supplement (the "Prospectus Supplement") to its effective registration statement on Form S-3ASR (File No. 333-278120) (the "Registration Statement") filed with the U.S. Securities and Exchange Commission, under the Securities Act of 1933, as amended, with respect to the resale by the selling shareholder named therein of up to 1,220,063 American Depositary Shares (the "Shares"), each representing the right to receive one ordinary share with a nominal value of £0.002 per share, of the Company.
Posted In: IMCR
